rxstat › Shortages › Ipratropium Bromide
Ipratropium Bromide shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Ipratropium Bromide products are in shortage in Canada (2 of 16 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Mar 10, 2017
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-IPRAVENT STERULES
0.025% · SOLUTION · APOTEX INC
DIN 02231494 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Active shortageAPO-IPRAVENT STERULES
125MCG · SOLUTION · APOTEX INC
DIN 02243827 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
ResolvedIPRAVENT
42MCG · SOLUTION · AA PHARMA INC
DIN 02246084 · ended Jun 30, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-IPRATROPIUM STERINEBS
250MCG · SOLUTION · TEVA CANADA LIMITED
DIN 02216221 · ended Jun 16, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-IPRATROPIUM STERINEBS
250MCG · SOLUTION · TEVA CANADA LIMITED
DIN 02216221 · ended Apr 3, 2026 · Disruption of the manufacture of the drug.
ResolvedPMS-IPRATROPIUM
125MCG · SOLUTION · PHARMASCIENCE INC
DIN 02231135 · ended Aug 15, 2025 · Disruption of the manufacture of the drug.
ResolvedPMS-IPRATROPIUM
250MCG · SOLUTION · PHARMASCIENCE INC
DIN 02231245 · ended Nov 28, 2025 · Disruption of the manufacture of the drug.
ResolvedPMS-IPRATROPIUM
250MCG · SOLUTION · PHARMASCIENCE INC
DIN 02231244 · ended Aug 15, 2025 · Disruption of the manufacture of the drug.
ResolvedPMS-IPRATROPIUM
250MCG · SOLUTION · PHARMASCIENCE INC
DIN 02231244 · ended Jan 23, 2026 · Disruption of the manufacture of the drug.
ResolvedPMS-IPRATROPIUM
125MCG · SOLUTION · PHARMASCIENCE INC
DIN 02231135 · ended Sep 15, 2025 · Disruption of the manufacture of the drug.
ResolvedJAMP IPRATROPIUM HFA
20MCG · METERED-DOSE AEROSOL · JAMP PHARMA CORPORATION
DIN 02542587 · ended Jun 16, 2025 · Disruption of the manufacture of the drug.
ResolvedPMS-IPRATROPIUM
250MCG · SOLUTION · PHARMASCIENCE INC
DIN 02231244 · ended Jan 14, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 56 reports. All reports are on file with Health Canada.
What's happening
Ipratropium Bromide is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Ipratropium Bromide is classified under “DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE” (ATC R01AX).
Recent changes
Common questions
When will Ipratropium Bromide be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Ipratropium Bromide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.